Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Read more about Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Nelfinavir Mesylate in Treating Patients With Kaposi Sarcoma Read more about Nelfinavir Mesylate in Treating Patients With Kaposi Sarcoma
Magrolimab Monotherapy or Magrolimab in Combination With Azacitidine in Participants With Hematological Malignancies Read more about Magrolimab Monotherapy or Magrolimab in Combination With Azacitidine in Participants With Hematological Malignancies
Study of Sparsentan in Patients With Primary Focal Segmental Glomerulosclerosis (FSGS) Read more about Study of Sparsentan in Patients With Primary Focal Segmental Glomerulosclerosis (FSGS)
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer Read more about Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Implementing a Virtual Tobacco Treatment for Cancer Patients in Community Oncology Practices Read more about Implementing a Virtual Tobacco Treatment for Cancer Patients in Community Oncology Practices
Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC) Read more about Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC)
Use of a Pre-Surgical Toolkit in Improving Surgical Care and Outcomes in Older Participants With Cancer Read more about Use of a Pre-Surgical Toolkit in Improving Surgical Care and Outcomes in Older Participants With Cancer
A Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer Read more about A Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer
A Study of PRT543 in Participants With Advanced Solid Tumors and Hematologic Malignancies Read more about A Study of PRT543 in Participants With Advanced Solid Tumors and Hematologic Malignancies